Main characteristics of hepatocellular carcinoma and cirrhosis and therapeutic approaches

被引:6
|
作者
Elba, S [1 ]
Buongiorno, GP [1 ]
Caruso, ML [1 ]
Noviello, MR [1 ]
Manghisi, OG [1 ]
机构
[1] IRCCS S De Bellis, Serv Radiol, Serv Anat Patol, Div Gastroenterol, Castellana Grotte, Italy
关键词
epidemiology; HCC; ultrasound; histology;
D O I
10.2174/1381612024607027
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Between 1995 and 1997 we studied 100 patients with hepatocarcinoma (HCC) and cirrhosis. Of these 74 were males and 26 females with a mean age of 66 years. 13% patients were only HbsAg positive, 75% only anti-HCV positive, 6% HbsAg and anti-HCV and the etiology in 6% of cases was alcoholic. Alpha-foetoprotein was >400ng/ml in only 18% of cases and portal thrombosis was present in 12%. Mononodular HCC was observed in 63% of cases (small HCC in only 38%) and in 79% was localized to the right lobe. Of the mononodular types, 70% were shown by echography to be hypoechoic, 6% hysoechoic, 6% hyperechoic and 17% mixed patterns. Histologically, 49% were well-differentiated, 45% moderately-differentiated and 6% poorly-differentiated. No correlation was found between histologic pattern and number of nodules. Well-differentiated HCC was found in 51% of mononodular types and in 46% of multinodular types. Moderately-differentiated HCC was detected in 46% and 43% respectively and poorly-differentiated HCC in 3% and 11% respectively. No correlation was found between number of nodules and the degree of Edmonson.
引用
收藏
页码:1007 / 1011
页数:5
相关论文
共 50 条
  • [21] Alcoholic Cirrhosis and Hepatocellular Carcinoma
    Stickel, Felix
    BIOLOGICAL BASIS OF ALCOHOL-INDUCED CANCER, 2015, 815 : 113 - 130
  • [22] AUTOANTIBODIES IN CIRRHOSIS AND HEPATOCELLULAR CARCINOMA
    LEE, AKY
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1973, 3 (03): : 268 - 271
  • [23] CIRRHOSIS AND HEPATOCELLULAR-CARCINOMA
    NEUBERGER, J
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1994, 6 (12) : 1119 - 1121
  • [24] Hepatocellular carcinoma (HCC) in multitransfused patients (pts) with thalassemia major (TM) Risk factors, characteristics and therapeutic approaches
    Kountouras, Dimitrios
    Kattamis, Antonios
    Kourakli, Alexandra
    Klironomos, Evanggelos
    Lafiatis, Ioannis
    Petropoulou, Fotini
    Maragkos, Konstantinos
    Farmaki, Kallistheni
    Vlachaki, Efthimia
    Koskinas, John
    HEPATOLOGY, 2017, 66 : 781A - 781A
  • [25] Molecular pathogenesis of hepatocellular carcinoma: New therapeutic approaches and predictive pathology
    Kern, M. A.
    Breuhahn, K.
    Schuchmann, M.
    Schirmacher, P.
    PATHOLOGE, 2007, 28 (04): : 261 - 268
  • [26] Intercellular communication in the tumour microecosystem: Mediators and therapeutic approaches for hepatocellular carcinoma
    Wang, Wan-Ting
    Jin, Wei-Lin
    Li, Xun
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2022, 1868 (12):
  • [27] Molecular and immunological paradigms of hepatocellular carcinoma: Special reference to therapeutic approaches
    Kabashima, Ayano
    Shimada, Shu
    Shimokawa, Masahiro
    Akiyama, Yoshimitsu
    Tanabe, Minoru
    Tanaka, Shinji
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2021, 28 (01) : 62 - 75
  • [28] Editorial: Novel therapeutic approaches for biliary tract cancer and hepatocellular carcinoma
    Bekric, Dino
    Tornesello, Maria Lina
    Ocker, Matthias
    Mayr, Christian
    Kiesslich, Tobias
    Neureiter, Daniel
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [29] Elucidating Therapeutic Effects on Patients with Hepatocellular Carcinoma and Main Portal Vein Thrombosis
    Chen, L-W
    Chien, R-N
    Fang, K-M
    Yen, C-L
    Chang, J-J
    Lee, T-S
    Liu, C-J
    HEPATO-GASTROENTEROLOGY, 2010, 57 (98) : 228 - 231
  • [30] Clinical Characterisation and Management of the Main Treatment-Induced Toxicities in Patients with Hepatocellular Carcinoma and Cirrhosis
    Meriggi, Fausto
    Graffeo, Massimo
    CANCERS, 2021, 13 (03) : 1 - 19